110 related articles for article (PubMed ID: 1851586)
1. [The distribution of HLA-system antigens in lung cancer patients].
Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
Tatsuno I; Konishi K
Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
6. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA].
Xue W; Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):63-7. PubMed ID: 1652380
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
[TBL] [Abstract][Full Text] [Related]
8. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
10. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
11. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
13. The relative radioresponsiveness of small cell lung cancer.
Ampil FL
Radiat Med; 1988; 6(6):282-4. PubMed ID: 2854900
[TBL] [Abstract][Full Text] [Related]
14. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer].
Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E
Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen fraction in lung cancer.
Fong S; Leon V; Betancourt M; Guarnaluse R
Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens and bronchogenic carcinoma in the Greek population.
Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
[TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
Kozielski J; Seweryn J
Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
[No Abstract] [Full Text] [Related]
18. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
20. [Dose multifractionation in radiotherapy of lung cancer of different histological types].
Leskov VP; Mardynskiĭ IuS
Med Radiol (Mosk); 1987 Jul; 32(7):30-3. PubMed ID: 3039285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
